Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
Sonrai Analytics
AI cancer pathology and genomics platform
Diagnostics & imagingHealth data & AI platforms
Belfast-founded, Queen's University spinout building an AI platform that reads cancer biopsy slides and multi-omic data to support faster, more consistent pathology diagnosis.
The read
Sonrai Analytics builds an AI platform that analyses cancer biopsy tissue images alongside multi-omic and clinical data, aiming to give pathologists a faster, more consistent second read on cases such as colorectal and lung cancer. It won an NHS AI in Health and Care Award, part of a national funding programme, to trial its cancer-screening AI across the health service, in partnership with the Precision Medicine Centre at Queen's University Belfast.
It has since broadened into partnerships with Roche, Cancer Research UK and drug-discovery partners including Candel Therapeutics, positioning its underlying data platform as infrastructure for pharma target identification as much as a frontline diagnostic tool.
The Bridgehead view
As one of the few Northern Ireland-headquartered names in this index, Sonrai's NHS AI Award win is a useful reminder that UK medtech isn't only an Oxford-Cambridge-London story, and that regional life-sciences clusters can win national-scale NHS procurement on technical merit.
Work with us
Working across the healthcare sector?
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
The firm that knows medtech
We map this sector because
we represent it.
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.
